Abstract
The fourth annual report of the South African Renal Registry summarises the 2015 data on renal replacement therapy (RRT) for patients with end-stage renal disease (ESRD) in South Africa. The South African population increased to 54.96 million in 2015, from 54.00 million in 2014. In December 2015, the number of patients with ESRD who were treated with chronic dialysis or transplantation stood at 10 360, a prevalence of 189 per million population (pmp). The prevalence was 167 pmp in 2013 and 178 pmp in 2014. The increasing prevalence observed is due mainly to the increased numbers of patients accessing haemodialysis in the private sector. In the public sector, which serves 84% of the South African population, the prevalence of RRT (71.9 pmp in 2015) remains at levels close to those reported in 1994 so that the disparity in access continues to increase. The disparities between provinces remain, with Limpopo and Mpumalanga the most under-served, as do the disparities between ethnic groups, with Blacks being the most under-served group.
Highlights
The South African Renal Society has mandated the South African Renal Registry (SARR) to collect, analyse and publish information on the treatment of patients with end-stage renal disease (ESRD) in South Africa
We suggest that the following criteria be met: by the World Bank, with a GNI per capita by the Atlas hypertension known to precede renal dysfunction, left method of $6 090 and by the purchasing power parity (PPP) method of $12 900
In 2014, the prevalence was 178 pmp. This growth was mainly due to an increase in the number of patients treated with haemodialysis in the private healthcare sector
Summary
The South African Renal Society has mandated the South African Renal Registry (SARR) to collect, analyse and publish information on the treatment of patients with end-stage renal disease (ESRD) in South Africa. We are pleased to present the fourth annual report of the SARR, which summarises the data on renal replacement therapy (RRT) for patients with ESRD in South Africa as at 31 December 2015. We are indebted to all our colleagues as well as the provider companies and their staff for contributing data, and to our sponsors for their continued support. We appreciate the funding and support received from the National Department of Health
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
